Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McGill University

$90,000.00

Optimizing DNA Nanotube Design for Drug Delivery to Tumours

FY 2009-10

Summary
Cancer remains the leading cause of death in Canada. This is despite the number of new drugs that have been developed over the past few decades. A major reason for this is that most cancer drugs are very poor at reaching tumours after they are injected into the body, and instead cause negative effects on healthy tissue. A highly promising approach for improving cancer treatment is therefore to increase how much of an injected drug reaches tumours and kills diseased cells. Researchers have found that nanometer sized particles can be used to deliver drugs to tumours more effectively. In fact, the use of nanoparticles can improve accumulation of a drug within tumours as much as ten-fold. Scientists have also found that the design of the nanoparticle (for example, size and shape) impacts how well they target tumours. Despite this finding, most research has focused on altering the particle size rather than the shape. One reason for this is that non-spheroid particles, such as longer filament particles, are difficult to synthesize. Recently, researchers at McGill University have developed methods of making nanotubes out of DNA. Even more importantly, they can carefully control the size of the DNA nanotubes. Because of this, it is now possible to test how filamentous nanoparticles of different lengths behave in the body and how well they accumulate in tumours. We will conduct a study to test what size (diameter and length) of DNA nanotubes are best for carrying drugs to tumours. The results of our research will allow new nanoparticle vehicles to be developed and will improve our ability to deliver drugs to tumours. This will allow for improvements in cancer treatment and a reduction in the side effects caused by the drugs.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
203966
Name
Perrault Steven D
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Optimizing DNA Nanotube Design for Drug Delivery to Tumours
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Dna Self-Assembly; Dna Synthesis; Drug Delivery; Nanoparticle Synthesis; Spectrophotometry; Survival Study; Transmission Electron Microscopy; Tumor Targeting; Xenograft Tumour
Abstract
Cancer remains the leading cause of death in Canada. This is despite the number of new drugs that have been developed over the past few decades. A major reason for this is that most cancer drugs are very poor at reaching tumours after they are injected into the body, and instead cause negative effects on healthy tissue. A highly promising approach for improving cancer treatment is therefore to increase how much of an injected drug reaches tumours and kills diseased cells. Researchers have found that nanometer sized particles can be used to deliver drugs to tumours more effectively. In fact, the use of nanoparticles can improve accumulation of a drug within tumours as much as ten-fold. Scientists have also found that the design of the nanoparticle (for example, size and shape) impacts how well they target tumours. Despite this finding, most research has focused on altering the particle size rather than the shape. One reason for this is that non-spheroid particles, such as longer filament particles, are difficult to synthesize. Recently, researchers at McGill University have developed methods of making nanotubes out of DNA. Even more importantly, they can carefully control the size of the DNA nanotubes. Because of this, it is now possible to test how filamentous nanoparticles of different lengths behave in the body and how well they accumulate in tumours. We will conduct a study to test what size (diameter and length) of DNA nanotubes are best for carrying drugs to tumours. The results of our research will allow new nanoparticle vehicles to be developed and will improve our ability to deliver drugs to tumours. This will allow for improvements in cancer treatment and a reduction in the side effects caused by the drugs.
Competitiondate
201002
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Perrault, Steven D
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~